Pay in 4 interest-free payments of $6.16 Learn more
Ships within 48 hours · Estimated delivery Nov 5 - Nov 10
According to Belle Health safety information, these medications are contraindicated for individuals with: Personal or family history of medullary thyroid carcinoma Multiple endocrine neoplasia syndrome type 2 (MEN2) History of pancreatitis Known hypersensitivity to tirzepatide or any of its components Additionally, women who are pregnant, planning to become pregnant, or breastfeeding should not use tirzepatide
Tirzepatide targets two hormonal pathways (GLP-1 and GIP) instead of one, and clinical trials consistently show it produces greater weight loss
All medications come from licensed 503A compounding pharmacies and are available across all 50 states without insurance requirements
Systemic Inflammation: Chronic platelet activation may drive systemic inflammatory cascades
Reduce dose by 25-50% and reassess
US$ 20.59
US$ 27.35
US$ 23.07
US$ 20.59
US$ 24.71
US$ 23.44
US$ 24.12
US$ 27.82
